Published in J Clin Invest on November 01, 1985
Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors. Proc Natl Acad Sci U S A (1990) 1.92
Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul (1991) 1.73
Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest (1986) 1.41
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest (2000) 1.30
Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem (2004) 1.24
Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats. J Clin Invest (1988) 1.14
Effect of Pasteurella multocida toxin on bone resorption in vitro. Infect Immun (1992) 1.07
Effects of DNA and prostaglandin synthesis inhibitors on the stimulation of bone resorption by epidermal growth factor in fetal rat long-bone cultures. J Clin Invest (1986) 1.01
Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest (1989) 1.00
Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice. J Clin Invest (1986) 0.95
Production and response of a human prostatic cancer line to transforming growth factor-like molecules. Br J Cancer (1990) 0.91
Ligand-bound thyroid hormone receptor contributes to reprogramming of pancreatic acinar cells into insulin-producing cells. J Biol Chem (2013) 0.88
Hydrolysis of transforming growth factor-alpha by cell-surface peptidases in vitro. Biochem J (1991) 0.88
Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways. PLoS One (2012) 0.87
Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats. Gut (1996) 0.81
Expression of transforming growth factor alpha (TGF-alpha) gene in mouse embryonic development. J Assist Reprod Genet (1997) 0.81
Incidence and pathophysiology of hypercalcemia. Calcif Tissue Int (1990) 0.79
Persistent expression of mitogenic/transforming factors at the site of failed orthopaedic implants: the impact on immune reactivity. J Mater Sci Mater Med (1998) 0.76
Opposite effects of transforming growth factor alpha and epidermal growth factor on mouse placental lactogen I secretion. Proc Natl Acad Sci U S A (1995) 0.76
Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty. Ann Rheum Dis (2000) 0.76
Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review. Am J Case Rep (2017) 0.75
Cardiotonic agent milrinone stimulates resorption in rodent bone organ culture. J Clin Invest (1987) 0.75
A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1970) 23.79
Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1978) 8.01
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A (1980) 6.32
Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell (1984) 5.39
Transforming growth factors from neoplastic and nonneoplastic tissues. Fed Proc (1983) 3.31
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med (1980) 3.15
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest (1983) 1.84
Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest (1983) 1.77
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1983) 1.75
A comparison of the binding of epidermal growth factor to cultured granulosa and luteal cells. J Biol Chem (1978) 1.53
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. Proc Natl Acad Sci U S A (1982) 1.44
Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. Biochem Biophys Res Commun (1978) 1.41
Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res (1983) 1.38
Direct stimulation of bone resorption by epidermal growth factor. Endocrinology (1980) 1.21
Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. Proc Natl Acad Sci U S A (1985) 1.13
EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. Endocrinology (1985) 1.11
Comparison of fetal rat limb bones and neonatal mouse calvaria: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3. Calcif Tissue Int (1983) 1.01
Epidermal growth factor receptors in clonal lines of a rat osteogenic sarcoma and in osteoblast-rich rat bone cells. Calcif Tissue Int (1983) 0.90
Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography. Anal Biochem (1980) 0.90
Potassium effects on bone: comparison of two model systems. Am J Physiol (1983) 0.84
Production of a macromolecular bone-resorbing factor by the hypercalcemic variant of the walker rat carcinosarcoma. Endocrinology (1984) 0.83
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature (1985) 13.04
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (1985) 10.13
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol (2001) 7.97
Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55
ACID-BASE EQUIVALENCE OF THE BLOOD IN DISEASES ASSOCIATED WITH HYPERGLOBULINEMIA; WITH SPECIAL REFERENCE TO LYMPHOGRANULOMA INGUINALE AND MULTIPLE MYELOMA. J Clin Invest (1936) 6.18
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol (1994) 6.00
Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell (1984) 5.39
Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature (1996) 5.30
TGF-beta signaling in cancer--a double-edged sword. Trends Cell Biol (2001) 4.87
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (1995) 4.56
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res (1987) 4.44
Characterization of broadly pleiotropic phenotypes caused by an hfq insertion mutation in Escherichia coli K-12. Mol Microbiol (1994) 4.34
Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature (1987) 4.19
Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation. Cancer Res (1985) 4.17
Isolation and structure of a human fibroblast interferon gene. Nature (1980) 4.16
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature (1998) 4.13
The murine transforming growth factor-beta precursor. J Biol Chem (1986) 3.67
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem (1986) 3.63
Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol (1990) 3.55
Toward a molecular understanding of skeletal development. Cell (1995) 3.55
Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science (1986) 3.52
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell (1987) 3.45
Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J (1988) 3.26
Malignant urachal lesions. J Urol (1984) 2.99
Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A (2001) 2.91
The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev (1998) 2.82
TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J (2001) 2.81
Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology (1998) 2.78
Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol (1997) 2.72
Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12. J Bacteriol (1997) 2.69
The primary structure of the Saccharomyces cerevisiae gene for 3-phosphoglycerate kinase. Nucleic Acids Res (1982) 2.67
Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell (1989) 2.65
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol (1997) 2.61
Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest (1987) 2.41
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J (2000) 2.41
Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell (1986) 2.41
Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol (1996) 2.36
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science (1993) 2.35
TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev (2001) 2.35
Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res (1997) 2.35
The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J Biol Chem (1989) 2.29
Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science (1993) 2.20
Depletion of the cellular amounts of the MutS and MutH methyl-directed mismatch repair proteins in stationary-phase Escherichia coli K-12 cells. J Bacteriol (1996) 2.10
Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J (1999) 2.06
Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol (1997) 2.05
Pausing of RNA polymerase during in vitro transcription of the tryptophan operon leader region. Biochemistry (1981) 2.04
Mismatch repair protein MutL becomes limiting during stationary-phase mutation. Genes Dev (1997) 2.03
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest (1979) 2.02
Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest (1994) 2.01
Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol (1989) 2.00
Structural analysis of the Escherichia coli K-12 hisT operon by using a kanamycin resistance cassette. J Bacteriol (1987) 1.97
Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol (2000) 1.94
Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development (1997) 1.91
Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene (1991) 1.88
Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol (1999) 1.87
Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology (1996) 1.86
Genetic and physiological relationships among the miaA gene, 2-methylthio-N6-(delta 2-isopentenyl)-adenosine tRNA modification, and spontaneous mutagenesis in Escherichia coli K-12. J Bacteriol (1989) 1.85
Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol (1993) 1.84
Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol Cell Biol (1988) 1.79
Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest (1983) 1.77
Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell (1987) 1.76
Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol (1989) 1.76
Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci U S A (1985) 1.75
Metabolic relationships between pyridoxine (vitamin B6) and serine biosynthesis in Escherichia coli K-12. J Bacteriol (1990) 1.74
Promoter- and attenuator-related metabolic regulation of the Salmonella typhimurium histidine operon. J Bacteriol (1978) 1.74
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73
Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A (2000) 1.73
Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul (1991) 1.73
Expression of human fibroblast interferon gene in Escherichia coli. Nature (1980) 1.72
Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J (1989) 1.70
Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development (1999) 1.69
Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci U S A (1986) 1.69
Evidence for a unique human fibroblast interferon (IFN-beta 1) chromosomal gene, devoid of intervening sequences. Nucleic Acids Res (1981) 1.67
Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Science (1993) 1.66
A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. EMBO J (1997) 1.65
Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem (1995) 1.64
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol (2006) 1.63
Altered 3'-terminal RNA structure in phage Qbeta adapted to host factor-less Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.62
Role of cyclic nucleotides in the transport of water and electrolytes. Adv Cyclic Nucleotide Res (1977) 1.62
Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys (1984) 1.62
Molecular mechanisms of nucleotide-sequence rearrangements in cDNA clones of human fibroblast interferon mRNA. Gene (1981) 1.60
Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet (1999) 1.60
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther (2008) 1.60
Computerized discharge summaries. Arch Phys Med Rehabil (1979) 1.60
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med (1978) 1.59
Nucleotide sequence of the chromosomal gene for human fibroblast (beta 1) interferon and of the flanking regions. Gene (1981) 1.58
Homomeric interactions between type II transforming growth factor-beta receptors. J Biol Chem (1994) 1.54
An Escherichia coli K-12 tktA tktB mutant deficient in transketolase activity requires pyridoxine (vitamin B6) as well as the aromatic amino acids and vitamins for growth. J Bacteriol (1994) 1.52
Possible mechanism for seeding of tumor during radical prostatectomy. J Urol (1993) 1.52